FDCC
SILK

Foster Dykema Cabot & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Foster Dykema Cabot & Co’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-109
Closed -$4K – 405
2023
Q2 		$4K Buy
+109
New +$3.98K ﹤0.01% 331

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Foster Dykema Cabot & Co's SILK Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2023, closing a stake of 109 shares — an estimated $4K sold.

Foster Dykema Cabot & Co first reported a position in SILK in Q2 2023 and held it in 1 quarter. The position peaked at $4K in Q2 2023. 166 funds tracked by Wall St. Rank hold SILK as of Q3 2023.

  • Foster Dykema Cabot & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Foster Dykema Cabot & Co sold 109 Silk Road Medical, Inc. Common Stock shares in Q3 2023, an estimated $4K.
  • Foster Dykema Cabot & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Foster Dykema Cabot & Co's Silk Road Medical, Inc. Common Stock position peaked at $4K in Q2 2023.
  • 166 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.